Management of treatment-emergent peripheral neuropathy in multiple myeloma

• Main Authors: Richardson, P.G., Delforge, M., Beksac, M., Wen, P., Jongen, J.L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S.V., Harousseau, J.L., Moreau, P., Avet-Loiseau, H., Lee, J.H., Cavo, M., Merlini, G., Voorhees, P., Chng, W.J., Mazumder, A., Usmani, S., Einsele, H., Comenzo, R., Orlowski, R., Vesole, D., Lahuerta, J.J., Niesvizky, R., Siegel, D., Mateos, M.-V., Dimopoulos, M., Lonial, S., Jagannath, S., Bladé, J., Miguel, J.S., Morgan, G., Anderson, K.C., Durie, B.G.M., Sonneveld, P.
• Other Authors: MEDICINE
• Format: Review
• Published: 2016
• Subjects: bortezomib; immunomodulatory drug; multiple myeloma; peripheral neuropathy; proteasome inhibitor; thalidomide
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/126928
• Institution: National University of Singapore

10.1038/leu.2011.346